Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Hold
154
0.55% 8
2026
Q1
$203K Buy
+154
New +$211K 0.41% 62
2024
Q1
Sell
-389
Closed -$294K 73
2023
Q4
$294K Hold
389
0.08% 83
2023
Q3
$229K Sell
389
-25
-6% -$16.6K 0.09% 79
2023
Q2
$300K Buy
414
+25
+6% +$17K 0.05% 114
2023
Q1
$265K Hold
389
0.04% 113
2022
Q4
$213K Hold
389
0.03% 89
2022
Q3
$162K Hold
389
0.07% 93
2022
Q2
$185K Hold
389
0.06% 105
2022
Q1
$260K Hold
389
0.07% 98
2021
Q4
$310K Buy
+389
New +$309K 0.08% 90
2021
Q2
Sell
-88
Closed -$54K 327
2021
Q1
$54K Hold
88
0.02% 232
2020
Q4
$43K Buy
+88
New +$37K 0.02% 111

Other funds holding ASML

Arlington Partners's ASML Position: Q2 2026 in Review

Arlington Partners held its ASML (ASML) position steady in Q2 2026 at 154 shares worth $306K. The position accounts for 0.55% of the portfolio, ranked #8.

Arlington Partners first reported a position in ASML in Q4 2020 and has held it in 13 quarters since. The position peaked at $310K in Q4 2021. 426 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Arlington Partners held 154 shares of ASML worth $306K as of Q2 2026.
  • Arlington Partners left its ASML share count unchanged in Q2 2026.
  • ASML made up 0.55% of Arlington Partners's portfolio in Q2 2026, its #8 holding.
  • Arlington Partners first reported a position in ASML in Q4 2020 and has held it in 13 quarters since.
  • Arlington Partners's ASML position peaked at $310K in Q4 2021.
  • 426 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.